Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CTBP1 inhibitors(C-terminal binding protein 1 inhibitors), CTBP2 inhibitors(C-terminal binding protein 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| high grade serous adenocarcinoma of ovary | Preclinical | United States | 20 Apr 2026 |





